What is the current Price Target for the Bioline RX Ltd Sponsored ADR stock?

The average Bioline RX Ltd Sponsored ADR target price is $26.00. This is 778.38% higher than the current stock price. The highest price target is 1,251.35%, the lowest is 305.41%. 3 Analysts have issued a price target Bioline RX Ltd Sponsored ADR 2026 .

How high will the Bioline RX Ltd Sponsored ADR stock rise?

No reliable answer can be given as to how high the Bioline RX Ltd Sponsored ADR stock will rise. The performance of stocks, including the Bioline RX Ltd Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Bioline RX Ltd Sponsored ADR stock today?

The performance of Bioline RX Ltd Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Bioline RX Ltd Sponsored ADR stock fall?

The decline in Bioline RX Ltd Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Bioline RX Ltd Sponsored ADR Forecast, price target & analysts

$2.99

0.93% today

Nasdaq, Dec 19, 05:13 pm CET

ISIN

US09071M1062

Symbol

BLRX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Bioline RX Ltd Sponsored ADR Target price 2025 - Analyst rating & recommendation

Bioline RX Ltd Sponsored ADR Price Target

Target Price	$26.00
Price	$2.96
Potential	778.38% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Bioline RX Ltd Sponsored ADR 2026 . The average Bioline RX Ltd Sponsored ADR target price is $26.00. This is 778.38% register free of charge higher than the current stock price. The highest price target is $40.00 1,251.35% register free of charge , the lowest is $12.00 305.41% register free of charge .
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Bioline RX Ltd Sponsored ADR stock has an average upside potential 2026 of 778.38% register free of charge .

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Revenue Million $	28.94	2.58
	502.92%	91.07%
EBITDA Margin	-64.37%	-402.53%
	92.65%	525.29%
Net Margin	-31.86%	-864.12%
	97.48%	2,612.32%

3 Analysts have issued a sales forecast Bioline RX Ltd Sponsored ADR 2025 . The average Bioline RX Ltd Sponsored ADR sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$28.9m	502.92%
2025	$2.6m 91.07% Unlock
2026	$7.3m 181.53% Unlock
2027	$11.3m 55.29% Unlock
2028	$13.7m 21.24% Unlock
2029	$18.5m 35.03% Unlock

1 Analyst has issued an EBITDA forecast Bioline RX Ltd Sponsored ADR 2025 . The average Bioline RX Ltd Sponsored ADR EBITDA estimate is

Unlock

. This is

Unlock

than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future EBITDA Margins:

2024	$-18.6m	55.71%
2025	$-10.4m 44.18% Unlock

2024	-64.37%	92.65%
2025	-402.53% 525.29% Unlock

1 Analyst has issued a net profit forecast Bioline RX Ltd Sponsored ADR 2025 . The average Bioline RX Ltd Sponsored ADR net profit estimate is

Unlock

. This is

Unlock

than the net profit for the last 12 months(TTM). The highest net profit forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future Net Margins:

2024	$-9.2m	84.79%
2025	$-22.3m 142.19% Unlock
2026	$0.0 100.00% Unlock

2024	-31.86%	97.48%
2025	-864.12% 2,612.32% Unlock
2026	0.00% 100.00% Unlock

Current Bioline RX Ltd Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 17 2025
Jones Trading	Locked ➜ Locked	Locked	May 30 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 28 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 17 2025
Locked Jones Trading: Locked ➜ Locked	May 30 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	May 28 2025

Discover more stocks with a high price target

Coinbase Global, Inc. 70.57%

BioNTech SE - ADR 56.13%

Deutsche Telekom 41.77%

Alibaba Group Holding Ltd 41.40%

Uber Technologies 40.80%

PayPal 37.28%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now